These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 31319159)

  • 1. Molecular mechanism for the activation of the anti-tuberculosis drug isoniazid by Mn(III): First detection and unequivocal identification of the critical N-centered isoniazidyl radical and its exact location.
    Qin L; Huang CH; Xu D; Xie LN; Shao J; Mao L; Kalyanaraman B; Zhu BZ
    Free Radic Biol Med; 2019 Nov; 143():232-239. PubMed ID: 31319159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism for the activation of the potent hepatotoxin acetylhydrazine: Identification of the initial N-centered radical and the secondary C-centered radical intermediates.
    Qin L; Huang CH; Liu CQ; Zhao CF; Li PL; Tang TS; Li J; Xie LN; Shao B; Shao J; Mao L; Li R; Zhang L; Zhu BZ
    Free Radic Biol Med; 2023 Aug; 204():20-27. PubMed ID: 37094755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First unequivocal identification of the critical acyl radicals from the anti-tuberculosis drug isoniazid and its hydrazide analogs by complementary applications of ESR spin-trapping and HPLC/MS methods.
    Qin L; Huang CH; Mao L; Shao B; Zhu BZ
    Free Radic Biol Med; 2020 Jul; 154():1-8. PubMed ID: 32360612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites.
    Khan SR; Morgan AG; Michail K; Srivastava N; Whittal RM; Aljuhani N; Siraki AG
    Biochem Pharmacol; 2016 Apr; 106():46-55. PubMed ID: 26867495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts.
    Nguyen M; Claparols C; Bernadou J; Meunier B
    Chembiochem; 2001 Dec; 2(12):877-83. PubMed ID: 11948876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and mechanism of oxidation of the anti-tubercular prodrug isoniazid and its analog by iridium(iv) as models for biological redox systems.
    Dong J; Ren Y; Sun S; Yang J; Nan C; Shi H; Xu J; Duan J; Shi T; Elding LI
    Dalton Trans; 2017 Jul; 46(26):8377-8386. PubMed ID: 28621793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).
    Wengenack NL; Rusnak F
    Biochemistry; 2001 Jul; 40(30):8990-6. PubMed ID: 11467961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
    Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
    J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of Isoniazid by Cytochromes P450: Analyzing the Molecular Mechanism using Density Functional Theory.
    Jaladanki CK; Shaikh A; Bharatam PV
    Chem Res Toxicol; 2017 Nov; 30(11):2060-2073. PubMed ID: 28950056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spin trapping of free radical intermediates produced during the metabolism of isoniazid and iproniazid in isolated hepatocytes.
    Albano E; Tomasi A
    Biochem Pharmacol; 1987 Sep; 36(18):2913-20. PubMed ID: 2820425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid: metabolic aspects and toxicological correlates.
    Preziosi P
    Curr Drug Metab; 2007 Dec; 8(8):839-51. PubMed ID: 18220565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD
    Babu D; Morgan AG; Reiz B; Whittal RM; Almas S; Lacy P; Siraki AG
    Chem Biol Interact; 2019 May; 305():48-53. PubMed ID: 30922765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radicals produced during the oxidation of hydrazines by hypochlorous acid.
    Goodwin DC; Aust SD; Grover TA
    Chem Res Toxicol; 1996 Dec; 9(8):1333-9. PubMed ID: 8951237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic activation of hydrazine derivatives. A spin-trapping study.
    Sinha BK
    J Biol Chem; 1983 Jan; 258(2):796-801. PubMed ID: 6296081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The mechanism of action of isoniazid. A chemical model of activation].
    Bernadou J; Nguyen M; Meunier B
    Ann Pharm Fr; 2001 Sep; 59(5):331-7. PubMed ID: 11787427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of mechanism of interaction of truncated isoniazid-nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach.
    Jena L; Deshmukh S; Waghmare P; Kumar S; Harinath BC
    Int J Mycobacteriol; 2015 Dec; 4(4):276-83. PubMed ID: 26964808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular details of INH-C10 binding to wt KatG and Its S315T mutant.
    Teixeira VH; Ventura C; Leitão R; Ràfols C; Bosch E; Martins F; Machuqueiro M
    Mol Pharm; 2015 Mar; 12(3):898-909. PubMed ID: 25590860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular investigation of active binding site of isoniazid (INH) and insight into resistance mechanism of S315T-MtKatG in Mycobacterium tuberculosis.
    Srivastava G; Tripathi S; Kumar A; Sharma A
    Tuberculosis (Edinb); 2017 Jul; 105():18-27. PubMed ID: 28610784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic study on the oxidation of hydrazides: application to the tuberculosis drug isoniazid.
    Amos RI; Gourlay BS; Schiesser CH; Smith JA; Yates BF
    Chem Commun (Camb); 2008 Apr; (14):1695-7. PubMed ID: 18368168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected activation of N-alkyl hydroxamic acids to produce reactive N-centered free radicals and DNA damage by carcinogenic chlorinated quinones under normal physiological conditions.
    Huang CH; Xu D; Qin L; Tang TS; Shan GQ; Xie LN; Li PL; Mao L; Shao J; Zhu BZ
    Free Radic Biol Med; 2020 Jan; 146():70-78. PubMed ID: 31626947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.